Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cytokine

• Publication date

  2003-02-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1043-4666(03)00076-0PMID 12788306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage migration inhibitory factor.

  2005cited by this paper
• Macrophage migration inhibitory factor in ocular fluids of patients with uveitis

  2001cited by this paper
• High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis.

  2001cited by this paper
• Macrophage migration inhibitory factor as a target molecule in multiple sclerosis.

  2001cited by this paper
• Quantification of constitutive endothelial and inducible nitric oxide synthase mRNA by competitive reverse transcription-polymerase chain reaction

  2001cited by this paper
• Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome

  2001cited by this paper
• Serum Levels of Macrophage Migration Inhibitory Factor in Various Types of Glomerulonephritis

  2000cited by this paper
• Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.

  2000cited by this paper
• IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.

  1999cited by this paper
• Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features

  1998cited by this paper
• An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

  1998cited by this paper
• The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat

  1997cited by this paper
• Role of macrophage migration inhibitory factor in the regulation of the immune response.

  1997cited by this paper
• Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome

  1997cited by this paper
• Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.

  1997cited by this paper
• Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor.

  1997cited by this paper
• De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.

  1996cited by this paper
• An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

  1996cited by this paper
• An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction

  1996cited by this paper
• Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

  1996cited by this paper
• Autoimmune versus inflammatory type I diabetes: a controversy?

  1995cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1995cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• Immunohistochemical Characterization of Monocytes-Macrophages and Dendritic Cells Involved in the Initiation of the Insulitis and β-Cell Destruction in NOD Mice

  1994cited by this paper
• Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?

  1994cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1993cited by this paper
• Morphological Analysis of Selective Destruction of Pancreatic β-cells by Cytotoxic T Lymphocytes in NOD Mice

  1991cited by this paper
• Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice

  1990cited by this paper
• Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma.

  1989cited by this paper
• Oxygen Free-Radical Scavengers and Immune Destruction of Murine Islets in Allograft Rejection and Multiple Low-Dose Streptozocin-Induced Insulitis

  1989cited by this paper
• Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.

  1988cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper
• Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice

  1986cited by this paper
• Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide

  1984cited by this paper
• Breeding of a non-obese, diabetic strain of mice.

  1980cited by this paper
• Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity

  1966cited by this paper
• Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

  1966cited by this paper

• Insulin Vesicle Substance That Physiologically Regulates Blood Glucose

  2025cites this paper
• Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategies.

  2021cites this paper
• Extracellular ATP Increases Glucose Metabolism in Skeletal Muscle Cells in a P2 Receptor Dependent Manner but Does Not Contribute to Palmitate-Induced Insulin Resistance

  2020cites this paper
• Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets.

  2019cites this paper
• MIF and insulin: Lifetime companions from common genesis to common pathogenesis.

  2019cites this paper
• The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review

  2019cites this paper
• Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review

  2018cites this paper
• Advances in Understanding the Role of MIF in the Pathogenesis of Autoimmune Diseases

  2017cites this paper
• Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

  2017cites this paper
• Proinflammatory cytokine MIF plays a role in the pathogenesis of type‐2 diabetes mellitus, but does not affect hepatic mitochondrial function

  2017cites this paper
• Altered Macrophage and Dendritic Cell Response in Mif−/− Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes

  2016cites this paper
• Protective Effect of Zengye Decoction (增液汤) on Submandibular Glands in Nonobese Diabetic Mice

  2014cites this paper
• Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell

  2014cites this paper
• Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.

  2014cites this paper
• The H1-Receptor Antagonist Cetirizine Protects Partially Against Cytokine- and Hydrogen Peroxide–Induced &bgr;-TC6 Cell Death In Vitro

  2014cites this paper
• The critical role of macrophage migration inhibitory factor in insulin activity.

  2014cites this paper
• Testing Agents for Prevention or Reversal of Type 1 Diabetes in Rodents

  2013cites this paper
• Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules.

  2013cites this paper
• Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine‐induced apoptosis in vitro

  2012cites this paper
• Beta cell function: the role of macrophage migration inhibitory factor

  2012cites this paper
• MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.

  2011cites this paper
• Tandem Repeats of the Catt Element of Macrophage Migration Inhibitory Factor Gene May Predict Gestational Diabetes Mellitus Severity

  2011cites this paper
• Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus

  2010cites this paper
• Macrophage Migration Inhibitory Factor: Critical Role in Obesity, Insulin Resistance, and Associated Comorbidities

  2010cites this paper
• Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism

  2010cites this paper
• Autoimmune diseases: MIF as a therapeutic target

  2010cites this paper
• Macrophage migration inhibitory factor is a therapeutic target in treatment of non‐insulin‐dependent diabetes mellitus

  2010cites this paper
• MIF in autoimmunity and novel therapeutic approaches.

  2009cites this paper
• The role of macrophage migration inhibitory factor on glucose metabolism and diabetes

  2008cites this paper
• Type 1 diabetes: can exercise impair the autoimmune event? The L‐arginine/glutamine coupling hypothesis

  2008cites this paper
• Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus

  2008cites this paper
• Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection

  2008cites this paper
• Aus der Deutschen Diabetes-Klinik des Deutschen Diabetes Zentrum -Leibniz-Institut- an der Heinrich- Heine- Universität Düsseldorf

  2007cites this paper
• Can perinatal supplementation of long-chain polyunsaturated fatty acids prevent atopy, bronchial asthma and other inflammatory conditions?

  2006cites this paper
• Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.

  2006cites this paper
• Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.

  2005cites this paper